5-150398379-AAAGAAG-AAAG
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2
The NM_001371623.1(TCOF1):c.4380_4382del(p.Lys1461del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00182 in 1,613,646 control chromosomes in the GnomAD database, including 7 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 6 hom. )
Consequence
TCOF1
NM_001371623.1 inframe_deletion
NM_001371623.1 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.32
Genes affected
TCOF1 (HGNC:11654): (treacle ribosome biogenesis factor 1) This gene encodes a nucleolar protein with a LIS1 homology domain. The protein is involved in ribosomal DNA gene transcription through its interaction with upstream binding factor (UBF). Mutations in this gene have been associated with Treacher Collins syndrome, a disorder which includes abnormal craniofacial development. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP3
?
Nonframeshift variant in repetitive region in NM_001371623.1
BP6
?
Variant 5-150398379-AAAG-A is Benign according to our data. Variant chr5-150398379-AAAG-A is described in ClinVar as [Benign]. Clinvar id is 209016.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-150398379-AAAG-A is described in Lovd as [Likely_benign].
BS1
?
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00121 (185/152328) while in subpopulation AMR AF= 0.00196 (30/15302). AF 95% confidence interval is 0.00167. There are 1 homozygotes in gnomad4. There are 84 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
?
High AC in GnomAd at 185 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TCOF1 | NM_001371623.1 | c.4380_4382del | p.Lys1461del | inframe_deletion | 25/27 | ENST00000643257.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TCOF1 | ENST00000643257.2 | c.4380_4382del | p.Lys1461del | inframe_deletion | 25/27 | NM_001371623.1 | P3 |
Frequencies
GnomAD3 genomes ? AF: 0.00122 AC: 185AN: 152210Hom.: 1 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
185
AN:
152210
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00117 AC: 290AN: 248098Hom.: 1 AF XY: 0.00128 AC XY: 172AN XY: 134446
GnomAD3 exomes
AF:
AC:
290
AN:
248098
Hom.:
AF XY:
AC XY:
172
AN XY:
134446
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00188 AC: 2754AN: 1461318Hom.: 6 AF XY: 0.00183 AC XY: 1333AN XY: 727000
GnomAD4 exome
AF:
AC:
2754
AN:
1461318
Hom.:
AF XY:
AC XY:
1333
AN XY:
727000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00121 AC: 185AN: 152328Hom.: 1 Cov.: 32 AF XY: 0.00113 AC XY: 84AN XY: 74492
GnomAD4 genome
?
AF:
AC:
185
AN:
152328
Hom.:
Cov.:
32
AF XY:
AC XY:
84
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Treacher Collins syndrome 1 Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 24, 2024 | - - |
Uncertain significance, no assertion criteria provided | not provided | Genetics Laboratories, Oxford Radcliffe Hospitals NHS Trust | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 20, 2019 | This variant is associated with the following publications: (PMID: 20003452) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at